HTA Conference 2024

Presentations

HTA in a Changing World: Navigating New Challenges and Opportunities


“Opening Remarks and Introduction to the 9th HTA Conference”

Yannis YFANTOPOULOS, Academic Coordinator MBA, University of Athens Health Services Management
Download the presentation

Impact of the New European Joint HTA Regulation on Healthcare Innovation and what lies beyond 2025″

Róisin ADAMS, Head at HTA Strategy and External Engagement, National Centre for Pharmacoeconomics (NCPE), Ireland
Download the presentation

Access and Reimbursement Strategies for Innovative Therapies from the Payers Perspective

Yannis NATSIS, Director of the European Social Insurance Platform (ESIP)
Download the presentation

Overview of measures affecting pharma policy and outcomes over the last decade”

Nikos MANIADAKIS, Professor of Health Services Evaluation, Management & Policy, Department of Public Health Policy, Univ. of West Attica
Download the presentation

Unlocking the Value of Pharmaceutical Innovation for Patients, Healthcare Systems and Society”

Romina SIATERLI, Policy and Communications Excellence Lead, Roche Hellas, and Member of the Policy Working Group, PhARMA Innovation Forum
Download the presentation

Proper evaluation of innovation and control of prescribing is our solution and our goal”

Babis KARATHANOS, Special Advisor to The Minister of Health
Download the presentation

HTA Enhancement in Greece through TSI Project

Vassilis KOUTSIOURIS, Office Director οf The General Secretariat οf Strategic Planning, Hellenic Ministry οf Health
Download the presentation

Challenges and Opportunities for Strengthening the HTA Institution, Process, and Methods

Flora BACOPOULOU, President of The HTA Committee, Associate Professor of Pediatrics – Adolescent Medicine, NKUA
Download the presentation

Industry Perspective on Navigating the new HTA landscape

Olympios PAPADIMITRIOU, President of the Association of Pharmaceutical Companies of Greece (SFEE) & General Manager, Novo Nordisk Hellas
Download the presentation

Unlocking Innovation and Streamlining Access: The Impact of EU HTA Regulation

Christian RODSETH, Vice-President PhARMA Innovation Forum, Managing Director, Janssen Greece, Poland & Romania
Download the presentation

Practical Aspects of the Reformation of HTA in Greece”

Zoe STEFANIDOU, Biologist, MSc In Health Policy, Head of International Market Access, ELPEN
Download the presentation

“Therapeutic protocols for managing cardiovascular diseases and their impact on patient outcomes”

Panos STAFYLAS, Cardiologist / HTA Consultant, Scientific Director Of HealThink, Greece
Download the presentation

Incorporating evidence-based strategies into ΗΤΑ

Antonis KAROKIS, External Affairs Director, MSD
Download the presentation

Implementation of therapeutic protocols in Oncology: Necessity and challenges”

George KAPETANAKIS, Chairman of The Board of Directors ELLOK, President of the Pieria Cancer Patients Association
Download the presentation

Importance of incorporating evidence-based therapeutic protocols in the HTA process for informed decision-making

Panagiota MITROU, Internist-Diabetologist, Head, Independent Dept of Therapeutic Protocols And Patient Registries, Ministry of Health
Download the presentation

Differences in access to ATMPS across Europe

Christos GEORGAKOPOULOS, Market Access Director, Hellenic Association of Pharmaceutical Companies (SFEE)
Download the presentation

Issues regarding Pricing and Access to Advanced Therapy Medicinal Products”

Lotte STEUTEN, Deputy Chief Executive, Office of Health Economics, London, UK, Hon. Visiting Prof. at City, London Univ. UK
Download the presentation